[HTML][HTML] Systemic inflammatory response and elevated tumour markers predict worse survival in resectable pancreatic ductal adenocarcinoma

A Salmiheimo, H Mustonen, UH Stenman… - PLoS …, 2016 - journals.plos.org
Background Estimation of the prognosis of resectable pancreatic ductal adenocarcinoma
(PDAC) currently relies on tumour-related factors such as resection margins and on lymph …

[PDF][PDF] Systemic Inflammatory Response and ElevatedTumour Markers Predict Worse Survival in ResectablePancreatic Ductal Adenocarcinoma

MH SalmiheimoA, UH Stenman, P Puolakkainen… - PLoS ONE, 2016 - core.ac.uk
Background Estimation of the prognosis of resectable pancreatic ductal adenocarcinoma
(PDAC) currently relies on tumour-related factors such as resection margins and on lymph …

Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma.

A Salmiheimo, H Mustonen, UH Stenman… - Plos one, 2016 - europepmc.org
Background Estimation of the prognosis of resectable pancreatic ductal adenocarcinoma
(PDAC) currently relies on tumour-related factors such as resection margins and on lymph …

Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma

A Salmiheimo, H Mustonen, UH Stenman… - PLoS ONE, 2016 - go.gale.com
Background Estimation of the prognosis of resectable pancreatic ductal adenocarcinoma
(PDAC) currently relies on tumour-related factors such as resection margins and on lymph …

[HTML][HTML] Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma

A Salmiheimo, H Mustonen, UH Stenman… - PLoS ONE, 2016 - ncbi.nlm.nih.gov
Background Estimation of the prognosis of resectable pancreatic ductal adenocarcinoma
(PDAC) currently relies on tumour-related factors such as resection margins and on lymph …

[引用][C] Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma

A Salmiheimo, H Mustonen, UH Stenman… - PLOS ONE, 2016 - cir.nii.ac.jp
Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in
Resectable Pancreatic Ductal Adenocarcinoma | CiNii Research CiNii 国立情報学研究所 学術 …

Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma

A Salmiheimo, H Mustonen, UH Stenman… - PLOS ONE, 2016 - ideas.repec.org
Background: Estimation of the prognosis of resectable pancreatic ductal adenocarcinoma
(PDAC) currently relies on tumour-related factors such as resection margins and on lymph …

Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma

A Salmiheimo, H Mustonen, UH Stenman… - PLOS …, 2016 - econpapers.repec.org
Background: Estimation of the prognosis of resectable pancreatic ductal adenocarcinoma
(PDAC) currently relies on tumour-related factors such as resection margins and on lymph …

Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma

A Salmiheimo, H Mustonen, UH Stenman… - PloS …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Estimation of the prognosis of resectable pancreatic ductal adenocarcinoma
(PDAC) currently relies on tumour-related factors such as resection margins and on lymph …

[PDF][PDF] Systemic Inflammatory Response and ElevatedTumour Markers Predict Worse Survival in ResectablePancreatic Ductal Adenocarcinoma

MH SalmiheimoA, UH Stenman… - PLoS …, 2016 - researchportal.helsinki.fi
Background Estimation of the prognosis of resectable pancreatic ductal adenocarcinoma
(PDAC) currently relies on tumour-related factors such as resection margins and on lymph …